As well as directly inhibiting tumor proliferation and targeting cancer stem-like cells, it also increases MHC expression and antigen presentation, thereby augmenting the functions of tumor-infiltrating adaptive immune cells including Th1 cells and cytotoxic T lymphocytes (CTLs). The gene discussed is HLA-C; the disease is neoplasm.